Glycine-modified ipamorelin: what forensic laboratories found in seized material

Published August 28, 2026 · Artemis Labs

Ipamorelin has an unusual published record for a research peptide: two independent forensic groups, working on different material in different countries, found that samples sold as ipamorelin were not ipamorelin. Both identified a modified version carrying one extra amino acid — glycine — added to the front of the chain. A German-led team reported it in black-market growth-promoting products in 2018 and confirmed the structure by synthesising the molecule themselves. A Danish team reported the same modification in powders seized by customs in 2019, across several peptides at once. Neither paper is about any particular seller. Both are about what a laboratory finds when it actually checks.

Key findings

• The 2018 study identified “three analogues of GHRPs … as Gly-GHRP-6, Gly-GHRP-2 and Gly-Ipamorelin, representing the corresponding GHRP extended by a N-terminal glycine residue” (PMID 29864719).
• Identity was not inferred. For Gly-ipamorelin and Gly-GHRP-2, it “was additionally confirmed by custom synthesis” — the authors made the molecule to check it matched.
• The 2019 study analyzed “unknown pharmaceutical preparations seized by Danish customs authorities” and found the same pattern: “In all cases, the detected modification involved the addition of an extra glycine amino acid at the N-terminus” (PMID 30136411).
• Its practical conclusion: “analytical methods targeting growth hormone secretagogues should hence be updated accordingly.”

What exactly was found

Ipamorelin’s chain begins with Aib, an unusual amino acid chosen partly because enzymes struggle to cut it. The modification these laboratories found adds a glycine — the smallest amino acid — in front of that.

The addition is small in mass and easy to miss. That is precisely why it matters analytically: a method built to detect ipamorelin by its expected mass can fail to see a molecule that is one glycine heavier, which is what prompted the Danish authors’ recommendation that detection methods be updated.

The 2018 paper found something else in the same investigation worth noting for scale: alongside the modified peptides, the team characterized a growth hormone variant carrying one extra alanine at its N-terminus, “leading to a monoisotopic mass of 22,195 Da” against the natural 22,124. The same pattern of small, deliberate-looking modifications appeared in a protein as well as in the peptides.

Why this belongs on a research supplier’s website

Two reasons, and neither is about us.

The first is scientific. If you are running an experiment, the identity of your material is a precondition for every result you get. A compound carrying an extra residue is a different molecule with potentially different receptor behavior. It would not be caught by a purity figure, because purity answers a different question: a sample can be overwhelmingly one substance and overwhelmingly the wrong substance at the same time. Purity and identity are separate questions, and this literature is a demonstration of why.

The second is that the finding is checkable. Two groups, two countries, two sets of material, one consistent result, one of them confirmed by synthesising the suspect molecule from scratch. That is a stronger evidence base than most claims made in this category, in either direction.

What this research does not do is tell you anything about any specific vendor, including this one. We make no analytical claim about our own material on this page or anywhere else. The value of these papers is that they describe a documented market-wide phenomenon, and a researcher who knows about it will ask better questions of any supplier.

How the identity question is actually answered

The methods in this literature are worth understanding because they are the same methods that answer the identity question generally.

Mass spectrometry measures a molecule’s mass very precisely, and tandem mass spectrometry breaks the molecule into fragments and measures those too — so a peptide can be read residue by residue rather than judged by its total weight alone. That fragment-level reading is how a one-glycine difference is spotted at all.

Liquid chromatography separates the components of a sample before they reach the detector, so that a minor component is not hidden by a major one. Together the two techniques are the standard identity toolkit for peptides, and they are what the anti-doping literature — which makes up a large share of all published ipamorelin research — has spent twenty years refining.

What the research does not show

These papers do not establish how common the modification is. They report what was in the samples that reached two laboratories, and seized material is not a random sample of anything.

They do not show that the modified peptide is more dangerous, or less active, or anything else about its biology. The studies are analytical chemistry: they establish what the molecule is, not what it does. The 2018 authors note only that “established in-vitro experiments provided preliminary information considering the potential metabolism after administration.”

And they say nothing about any particular supplier’s material. No page on this site claims that our own product has been tested against these findings, because we publish no analytical claims of our own.

Frequently asked questions

What is Gly-ipamorelin?

Ipamorelin with an additional glycine residue attached to the start of the chain. It was identified in seized and black-market material by two independent forensic groups and confirmed by chemical synthesis in one of them.

Would a purity test catch this?

Not necessarily. A purity measurement asks how much of the sample is one substance. Identifying which substance requires methods that read the molecule’s structure, such as tandem mass spectrometry.

Does this mean ipamorelin sold anywhere is fake?

No, and neither paper says that. They report what specific seized samples contained. The general lesson is that identity is a question worth asking, not that any particular answer is guaranteed.

Where can I read the exact identity fields for ipamorelin?

Our sequence and identity page lists the verified sequence, formula, molecular weight, CAS number and PubChem record, with the source for each.

References

1. Krug O, Thomas A, Malerød-Fjeld H, Dehnes Y, Laussmann T, Feldmann I, et al. Growth Horm IGF Res. 2018. PMID 29864719. DOI 10.1016/j.ghir.2018.05.001.
2. Gajda PM, Holm NB, Hoej LJ, Rasmussen BS, Dalsgaard PW, Reitzel LA, et al. Drug Test Anal. 2019. PMID 30136411. DOI 10.1002/dta.2489.
3. Thomas A, Delahaut P, Krug O, Schänzer W, Thevis M. Anal Chem. 2012. PMID 23101768.
4. Thomas A, et al. J Sep Sci. 2016. PMID 26578461.

Methodology: quotations are verbatim from the published abstracts of the two forensic studies, retrieved through NCBI E-utilities on August 28, 2026. This page makes no analytical claim about Artemis Labs material.

All compounds sold by Artemis Labs are for laboratory research use only. Nothing on this page is medical advice, and no statement has been evaluated by the FDA.